These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 21538846)

  • 41. Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.
    Jung YD; Ellis LM
    Int J Exp Pathol; 2001 Dec; 82(6):309-16. PubMed ID: 11846837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular Targets of Epigallocatechin-Gallate (EGCG): A Special Focus on Signal Transduction and Cancer.
    Negri A; Naponelli V; Rizzi F; Bettuzzi S
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30563268
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medicinal benefits of green tea: part II. review of anticancer properties.
    Cooper R; Morré DJ; Morré DM
    J Altern Complement Med; 2005 Aug; 11(4):639-52. PubMed ID: 16131288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Possible Mechanisms of Green Tea and Its Constituents against Cancer.
    Shirakami Y; Shimizu M
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30205425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular mechanisms explaining the preventive effects of catechins on the development of proliferative diseases.
    Gouni-Berthold I; Sachinidis A
    Curr Pharm Des; 2004; 10(11):1261-71. PubMed ID: 15078140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigallocatechin gallate (EGCG) inhibits type II phosphatidylinositol 4-kinases: a key component in pathways of phosphoinositide turnover.
    Sinha RK; Patel RY; Bojjireddy N; Datta A; Subrahmanyam G
    Arch Biochem Biophys; 2011 Dec; 516(1):45-51. PubMed ID: 21964243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cancer chemoprevention with green tea catechins: from bench to bed.
    Shirakami Y; Shimizu M; Moriwaki H
    Curr Drug Targets; 2012 Dec; 13(14):1842-57. PubMed ID: 23140294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives.
    Nagle DG; Ferreira D; Zhou YD
    Phytochemistry; 2006 Sep; 67(17):1849-55. PubMed ID: 16876833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Green tea catechins: Proposed mechanisms of action in breast cancer focusing on the interplay between survival and apoptosis.
    Yiannakopoulou ECh
    Anticancer Agents Med Chem; 2014 Feb; 14(2):290-5. PubMed ID: 24069935
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Green tea catechins: a fresh flavor to anticancer therapy.
    Yu Y; Deng Y; Lu BM; Liu YX; Li J; Bao JK
    Apoptosis; 2014 Jan; 19(1):1-18. PubMed ID: 24081390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents.
    Colomer R; Sarrats A; Lupu R; Puig T
    Curr Drug Targets; 2017; 18(2):147-159. PubMed ID: 26758667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Advance in anticancer studies on catechins and their derivatives].
    Zhou J; Gong ZL; Zhang K; Ding YP
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(17):2510-8. PubMed ID: 23236742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The inhibitory effect of ECG and EGCG dimeric procyanidins on colorectal cancer cells growth is associated with their actions at lipid rafts and the inhibition of the epidermal growth factor receptor signaling.
    Zhu W; Li MC; Wang FR; Mackenzie GG; Oteiza PI
    Biochem Pharmacol; 2020 May; 175():113923. PubMed ID: 32217102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epigallocatechin gallate inhibits human tongue carcinoma cells via HK2‑mediated glycolysis.
    Gao F; Li M; Liu WB; Zhou ZS; Zhang R; Li JL; Zhou KC
    Oncol Rep; 2015 Mar; 33(3):1533-9. PubMed ID: 25591943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Downstream carcinogenesis signaling pathways by green tea polyphenols: a translational perspective of chemoprevention and treatment for cancers.
    Hu G; Zhang L; Rong Y; Ni X; Sun Y
    Curr Drug Metab; 2014 Jan; 15(1):14-22. PubMed ID: 24329111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biophysical Approach to Mechanisms of Cancer Prevention and Treatment with Green Tea Catechins.
    Suganuma M; Takahashi A; Watanabe T; Iida K; Matsuzaki T; Yoshikawa HY; Fujiki H
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27869750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential role of green tea catechins in various disease therapies: progress and promise.
    Mak JC
    Clin Exp Pharmacol Physiol; 2012 Mar; 39(3):265-73. PubMed ID: 22229384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention.
    Rocha S; Generalov R; Pereira Mdo C; Peres I; Juzenas P; Coelho MA
    Nanomedicine (Lond); 2011 Jan; 6(1):79-87. PubMed ID: 21182420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Catechins and Its Role in Chronic Diseases.
    Shirakami Y; Sakai H; Kochi T; Seishima M; Shimizu M
    Adv Exp Med Biol; 2016; 929():67-90. PubMed ID: 27771921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer.
    Connors SK; Chornokur G; Kumar NB
    Nutr Cancer; 2012; 64(1):4-22. PubMed ID: 22098273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.